Search research articles
Contact Us
Filters
Showing results (141-150 of 159) with videos related to
Page
of 16
Sort By:
Molecular Psychiatry
|
February 7, 2022
Relationship between astrocyte reactivity, using novel <sup>11</sup>C-BU99008 PET, and glucose metabolism, grey matter volume and amyloid load in cognitively impaired individuals
Nicholas R Livingston, Valeria Calsolaro, Rainer Hinz, et al.
Brain Connectivity
|
January 31, 2023
European Working Group on SARS-CoV-2: Current Understanding, Unknowns, and Recommendations on the Neurological Complications of COVID-19
Harry Crook, Alfredo Ramirez, Akram Hosseini, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
September 11, 2012
A European multicentre PET study of fibrillar amyloid in Alzheimer's disease
Agneta Nordberg, Stephen F Carter, Juha Rinne, et al.
Alzheimer'S Research & Therapy
|
December 4, 2025
Longitudinal biomarker studies in human neuroimaging: capturing biological change of Alzheimer's pathology
Larissa Fischer, Dana Parker, Samira Maboudian, et al.
Nature Medicine
|
October 16, 2021
Publisher Correction: Microglial activation and tau propagate jointly across Braak stages
Tharick A Pascoal, Andrea L Benedet, Nicholas J Ashton, et al.
Molecular Psychiatry
|
July 16, 2021
Astrocyte reactivity with late-onset cognitive impairment assessed in vivo using <sup>11</sup>C-BU99008 PET and its relationship with amyloid load
Valeria Calsolaro, Paul M Matthews, Cornelius K Donat, et al.
Nature Medicine
|
August 27, 2021
Microglial activation and tau propagate jointly across Braak stages
Tharick A Pascoal, Andrea L Benedet, Nicholas J Ashton, et al.
JAMA Network Open
|
January 13, 2023
Analysis of Psychological Symptoms Following Disclosure of Amyloid-Positron Emission Tomography Imaging Results to Adults With Subjective Cognitive Decline
Camilla Caprioglio, Federica Ribaldi, Leonie N C Visser, et al.
European Journal of Neurology
|
June 24, 2025
Utility, Costs and Cost-Utility of Amyloid-PET in the Diagnostic Process of Memory Clinic Patients: A Trial-Based Economic Evaluation From AMYPAD-DPMS
Ingrid S van Maurik, Daniele Altomare, Lyduine E Collij, et al.
Molecular Psychiatry
|
September 4, 2025
Association between FDG- and TSPO-PET signals across human and animal studies investigating neurodegenerative conditions: a systematic review
Luiza S Machado, Pedro Vidor, Lavínia Perquim, et al.
Page
of 16
Search research articles
Search
Showing results (141-150 of 159) with videos related to
Sort By:
Page
of 16
Molecular Psychiatry
|
February 7, 2022
Relationship between astrocyte reactivity, using novel <sup>11</sup>C-BU99008 PET, and glucose metabolism, grey matter volume and amyloid load in cognitively impaired individuals
Nicholas R Livingston, Valeria Calsolaro, Rainer Hinz, et al.
Brain Connectivity
|
January 31, 2023
European Working Group on SARS-CoV-2: Current Understanding, Unknowns, and Recommendations on the Neurological Complications of COVID-19
Harry Crook, Alfredo Ramirez, Akram Hosseini, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
September 11, 2012
A European multicentre PET study of fibrillar amyloid in Alzheimer's disease
Agneta Nordberg, Stephen F Carter, Juha Rinne, et al.
Alzheimer'S Research & Therapy
|
December 4, 2025
Longitudinal biomarker studies in human neuroimaging: capturing biological change of Alzheimer's pathology
Larissa Fischer, Dana Parker, Samira Maboudian, et al.
Nature Medicine
|
October 16, 2021
Publisher Correction: Microglial activation and tau propagate jointly across Braak stages
Tharick A Pascoal, Andrea L Benedet, Nicholas J Ashton, et al.
Molecular Psychiatry
|
July 16, 2021
Astrocyte reactivity with late-onset cognitive impairment assessed in vivo using <sup>11</sup>C-BU99008 PET and its relationship with amyloid load
Valeria Calsolaro, Paul M Matthews, Cornelius K Donat, et al.
Nature Medicine
|
August 27, 2021
Microglial activation and tau propagate jointly across Braak stages
Tharick A Pascoal, Andrea L Benedet, Nicholas J Ashton, et al.
JAMA Network Open
|
January 13, 2023
Analysis of Psychological Symptoms Following Disclosure of Amyloid-Positron Emission Tomography Imaging Results to Adults With Subjective Cognitive Decline
Camilla Caprioglio, Federica Ribaldi, Leonie N C Visser, et al.
European Journal of Neurology
|
June 24, 2025
Utility, Costs and Cost-Utility of Amyloid-PET in the Diagnostic Process of Memory Clinic Patients: A Trial-Based Economic Evaluation From AMYPAD-DPMS
Ingrid S van Maurik, Daniele Altomare, Lyduine E Collij, et al.
Molecular Psychiatry
|
September 4, 2025
Association between FDG- and TSPO-PET signals across human and animal studies investigating neurodegenerative conditions: a systematic review
Luiza S Machado, Pedro Vidor, Lavínia Perquim, et al.
Page
of 16